Semaglutide ml to Units: Why the Conversion Matters for Your Treatment

Why this conversion question rarely applies to licensed semaglutide

Wegovy, the licensed semaglutide injection for weight management in the UK, comes as a pre-filled, single-patient-use pen. The dose is dialled in at the factory. You press the button; the pen delivers exactly the prescribed amount. There is no vial, no syringe, no calculation. The same is true of Ozempic, the semaglutide pen licensed for type 2 diabetes. Neither product requires (or even permits) the patient to convert millilitres into semaglutide units.

So when someone asks how many units are in 0.25 ml of semaglutide, or how to draw up a dose from a vial, they are almost certainly looking at a product outside the licensed supply chain. That might be a compounded preparation, a product imported without UK marketing authorisation, or something sold through social media or an unverified website. The concentration of semaglutide in those products varies enormously, which is precisely why the ml-to-units question has no single answer: 0.5 ml at one concentration is not the same dose as 0.5 ml at another. There is no universal conversion table because there is no standardised unlicensed formulation.

The NHS semaglutide medicines page describes the approved forms of the medicine clearly, and it does not mention vials or unit-based dosing for weight management, because those forms are not part of the licensed product. That absence is informative.

The specific risk when you calculate rather than use a pre-set pen

There is a common assumption that if you know the concentration on the label, the arithmetic is safe. It rarely is in practice. Compounded semaglutide products vary in concentration between batches and between suppliers. A 10 mg/ml vial and a 5 mg/ml vial look similar; an error in reading a label or misremembering a previous product's concentration can result in a dose twice or half what was intended.

This is not a theoretical concern. The MHRA has seized large volumes of fake and unlicensed weight-loss injectable products and warned that some have caused serious harm, including cases where products contained the wrong active ingredient entirely. Reporting a suspect product or seller is straightforward via the MHRA's Yellow Card scheme, which accepts reports from patients as well as clinicians.

A prescriber working within a GPhC-registered pharmacy will never ask you to calculate your own dose from a vial. If someone has, that is worth pausing on. You can read more about how licensed semaglutide works and what the approved treatment pathway looks like.

What semaglutide units actually refer to, and why the figure shifts

In diabetes care, insulin doses are expressed in units because insulin is standardised to an international unit definition. Semaglutide is not insulin and has no equivalent international unit standard, it is measured in milligrams. When people refer to semaglutide "units", they are usually describing the graduation marks on an insulin syringe being repurposed to draw up a compounded preparation. The number of milligrams those marks correspond to depends entirely on the concentration of the specific vial being used. Ten marks on a U-100 insulin syringe equals 0.1 ml; at 10 mg/ml that would be 1 mg of semaglutide; at 2 mg/ml it would be 0.2 mg. The arithmetic changes completely with each product.

For context, the licensed Wegovy maintenance dose is 2.4 mg per week, titrated upward from 0.25 mg under prescriber supervision, details that the Wegovy Summary of Product Characteristics on the eMC sets out precisely, alongside storage requirements and contraindications. Someone managing that titration from a vial with a syringe, without prescriber oversight, has no reliable way to replicate those doses safely.

If you're thinking about what 5 units or 10 units of semaglutide corresponds to in a compounded product, the honest answer is: it depends on what product you have, and the right person to answer that is a prescriber who can review the specific formulation, not a conversion guide online. Pages like our explainer on 5 units of semaglutide and 10 units of semaglutide go into more depth on how those figures arise and what they mean in practice, and our page on what 15 units of semaglutide means in practice explains how the same arithmetic applies at higher syringe readings.

The licensed route and what it looks like instead

If weight management with semaglutide is the goal, the licensed route in the UK starts with a clinical consultation. A prescriber assesses eligibility, reviews any other medicines, checks for contraindications and sets the starting dose. Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above with a weight-related health condition such as high blood pressure or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

At a GPhC-registered pharmacy, the medicine arrives as a factory-sealed pen, at the prescribed strength, with the patient information leaflet inside. There is no vial. There is no syringe. There is no conversion calculation. That is not a quirk of the product, it is the design. Our guide to Wegovy pricing covers what a legitimate private prescription includes, which is worth reading alongside this if cost has been part of what made an unlicensed product look attractive.

If you are weighing up your options or want to understand what a proper clinical assessment involves, our weight-loss treatment overview sets out what the process looks like from the first question to the first pen, and if you want to know what to expect once treatment begins, our guide to the second week of Wegovy covers the changes and side effects that commonly arise early in the titration schedule. A good starting point is to start your free consultation with one of our prescribers, who can advise on whether Wegovy or another licensed treatment suits your situation.